JPMA to Present Proposal on Value-Based Drug Pricing at Upcoming Panel Hearing

JPMA Director General Junichi Shiraishi The Japan Pharmaceutical Manufacturers Association (JPMA) plans to present its proposal on value-based pricing for innovative medicines as well as its views on the planned FY2023 off-year price revision at an upcoming hearing of a...read more